Clinical Trial Update: Urine Metabolites in the Diagnosis of Disease

View source ↗

Summary

Luventix, Inc. is sponsoring a clinical trial that investigates urine metabolites for disease diagnosis and is currently recruiting, targeting colorectal cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease
• Colorectal Cancer
• Crohn Disease
• Small Intestinal Bacterial Overgrowth

Snippet

Sponsor: Luventix, Inc. | Conditions: Colorectal Cancer, Small Intestinal Bacterial Overgrowth Syndrome (SIBO) | Status: RECRUITING